RI-1: A chemical inhibitor of RAD51 that disrupts Homologous recombination in human cells

Brian Budke, Hillary L. Logan, Jay H. Kalin, Anna S. Zelivianskaia, William Cameron McGuire, Luke L. Miller, Jeremy M. Stark, Alan P. Kozikowski, Douglas K. Bishop, Philip P. Connell

Research output: Contribution to journalArticle

Abstract

Homologous recombination serves multiple roles in DNA repair that are essential for maintaining genomic stability. We here describe RI-1, a small molecule that inhibits the central recombination protein RAD51. RI-1 specifically reduces gene conversion in human cells while stimulating single strand annealing. RI-1 binds covalently to the surface of RAD51 protein at cysteine 319 that likely destabilizes an interface used by RAD51 monomers to oligomerize into filaments on DNA. Correspondingly, the molecule inhibits the formation of subnuclear RAD51 foci in cells following DNA damage, while leaving replication protein A focus formation unaffected. Finally, it potentiates the lethal effects of a DNA cross-linking drug in human cells. Given that this inhibitory activity is seen in multiple human tumor cell lines, RI-1 holds promise as an oncologic drug. Furthermore, RI-1 represents a unique tool to dissect the network of reaction pathways that contribute to DNA repair in cells.

Original languageEnglish (US)
Pages (from-to)7347-7357
Number of pages11
JournalNucleic Acids Research
Volume40
Issue number15
DOIs
StatePublished - Aug 2012
Externally publishedYes

Fingerprint

Homologous Recombination
Rad51 Recombinase
DNA Repair
Replication Protein A
Gene Conversion
Genomic Instability
DNA
Tumor Cell Line
Pharmaceutical Preparations
Genetic Recombination
DNA Damage
Cysteine
Membrane Proteins

ASJC Scopus subject areas

  • Genetics

Cite this

Budke, B., Logan, H. L., Kalin, J. H., Zelivianskaia, A. S., McGuire, W. C., Miller, L. L., ... Connell, P. P. (2012). RI-1: A chemical inhibitor of RAD51 that disrupts Homologous recombination in human cells. Nucleic Acids Research, 40(15), 7347-7357. https://doi.org/10.1093/nar/gks353

RI-1 : A chemical inhibitor of RAD51 that disrupts Homologous recombination in human cells. / Budke, Brian; Logan, Hillary L.; Kalin, Jay H.; Zelivianskaia, Anna S.; McGuire, William Cameron; Miller, Luke L.; Stark, Jeremy M.; Kozikowski, Alan P.; Bishop, Douglas K.; Connell, Philip P.

In: Nucleic Acids Research, Vol. 40, No. 15, 08.2012, p. 7347-7357.

Research output: Contribution to journalArticle

Budke, B, Logan, HL, Kalin, JH, Zelivianskaia, AS, McGuire, WC, Miller, LL, Stark, JM, Kozikowski, AP, Bishop, DK & Connell, PP 2012, 'RI-1: A chemical inhibitor of RAD51 that disrupts Homologous recombination in human cells', Nucleic Acids Research, vol. 40, no. 15, pp. 7347-7357. https://doi.org/10.1093/nar/gks353
Budke B, Logan HL, Kalin JH, Zelivianskaia AS, McGuire WC, Miller LL et al. RI-1: A chemical inhibitor of RAD51 that disrupts Homologous recombination in human cells. Nucleic Acids Research. 2012 Aug;40(15):7347-7357. https://doi.org/10.1093/nar/gks353
Budke, Brian ; Logan, Hillary L. ; Kalin, Jay H. ; Zelivianskaia, Anna S. ; McGuire, William Cameron ; Miller, Luke L. ; Stark, Jeremy M. ; Kozikowski, Alan P. ; Bishop, Douglas K. ; Connell, Philip P. / RI-1 : A chemical inhibitor of RAD51 that disrupts Homologous recombination in human cells. In: Nucleic Acids Research. 2012 ; Vol. 40, No. 15. pp. 7347-7357.
@article{cc581bdcffa64425bee6b1e418ef769c,
title = "RI-1: A chemical inhibitor of RAD51 that disrupts Homologous recombination in human cells",
abstract = "Homologous recombination serves multiple roles in DNA repair that are essential for maintaining genomic stability. We here describe RI-1, a small molecule that inhibits the central recombination protein RAD51. RI-1 specifically reduces gene conversion in human cells while stimulating single strand annealing. RI-1 binds covalently to the surface of RAD51 protein at cysteine 319 that likely destabilizes an interface used by RAD51 monomers to oligomerize into filaments on DNA. Correspondingly, the molecule inhibits the formation of subnuclear RAD51 foci in cells following DNA damage, while leaving replication protein A focus formation unaffected. Finally, it potentiates the lethal effects of a DNA cross-linking drug in human cells. Given that this inhibitory activity is seen in multiple human tumor cell lines, RI-1 holds promise as an oncologic drug. Furthermore, RI-1 represents a unique tool to dissect the network of reaction pathways that contribute to DNA repair in cells.",
author = "Brian Budke and Logan, {Hillary L.} and Kalin, {Jay H.} and Zelivianskaia, {Anna S.} and McGuire, {William Cameron} and Miller, {Luke L.} and Stark, {Jeremy M.} and Kozikowski, {Alan P.} and Bishop, {Douglas K.} and Connell, {Philip P.}",
year = "2012",
month = "8",
doi = "10.1093/nar/gks353",
language = "English (US)",
volume = "40",
pages = "7347--7357",
journal = "Nucleic Acids Research",
issn = "1362-4962",
publisher = "Oxford University Press",
number = "15",

}

TY - JOUR

T1 - RI-1

T2 - A chemical inhibitor of RAD51 that disrupts Homologous recombination in human cells

AU - Budke, Brian

AU - Logan, Hillary L.

AU - Kalin, Jay H.

AU - Zelivianskaia, Anna S.

AU - McGuire, William Cameron

AU - Miller, Luke L.

AU - Stark, Jeremy M.

AU - Kozikowski, Alan P.

AU - Bishop, Douglas K.

AU - Connell, Philip P.

PY - 2012/8

Y1 - 2012/8

N2 - Homologous recombination serves multiple roles in DNA repair that are essential for maintaining genomic stability. We here describe RI-1, a small molecule that inhibits the central recombination protein RAD51. RI-1 specifically reduces gene conversion in human cells while stimulating single strand annealing. RI-1 binds covalently to the surface of RAD51 protein at cysteine 319 that likely destabilizes an interface used by RAD51 monomers to oligomerize into filaments on DNA. Correspondingly, the molecule inhibits the formation of subnuclear RAD51 foci in cells following DNA damage, while leaving replication protein A focus formation unaffected. Finally, it potentiates the lethal effects of a DNA cross-linking drug in human cells. Given that this inhibitory activity is seen in multiple human tumor cell lines, RI-1 holds promise as an oncologic drug. Furthermore, RI-1 represents a unique tool to dissect the network of reaction pathways that contribute to DNA repair in cells.

AB - Homologous recombination serves multiple roles in DNA repair that are essential for maintaining genomic stability. We here describe RI-1, a small molecule that inhibits the central recombination protein RAD51. RI-1 specifically reduces gene conversion in human cells while stimulating single strand annealing. RI-1 binds covalently to the surface of RAD51 protein at cysteine 319 that likely destabilizes an interface used by RAD51 monomers to oligomerize into filaments on DNA. Correspondingly, the molecule inhibits the formation of subnuclear RAD51 foci in cells following DNA damage, while leaving replication protein A focus formation unaffected. Finally, it potentiates the lethal effects of a DNA cross-linking drug in human cells. Given that this inhibitory activity is seen in multiple human tumor cell lines, RI-1 holds promise as an oncologic drug. Furthermore, RI-1 represents a unique tool to dissect the network of reaction pathways that contribute to DNA repair in cells.

UR - http://www.scopus.com/inward/record.url?scp=84867300763&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84867300763&partnerID=8YFLogxK

U2 - 10.1093/nar/gks353

DO - 10.1093/nar/gks353

M3 - Article

C2 - 22573178

AN - SCOPUS:84867300763

VL - 40

SP - 7347

EP - 7357

JO - Nucleic Acids Research

JF - Nucleic Acids Research

SN - 1362-4962

IS - 15

ER -